Osteoporosis: A still increasing prevalence

Bone

Volumn 38, Issue 2 SUPPL. 1, 2006, Pages 4-9

  Reginster, Jean Yves ^a,b   Burlet, Nansa ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Fracture; Morbidity; Osteoporosis; Quality of life; Risk assessment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; FLUORIDE; PARATHYROID HORMONE; PHOSPHONIC ACID DERIVATIVE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STRONTIUM RANELATE; UNCLASSIFIED DRUG;

ELDERLY CARE; EUROPE; FRAGILITY FRACTURE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; MORBIDITY; MORTALITY; OSTEOPOROSIS; PATIENT EDUCATION; POSTMENOPAUSE; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT;

EID: 31944443249     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.11.024     Document Type: Article

References (46)

1. C. Cooper Epidemiology of osteoporosis Osteoporos. Int. 9 Suppl 2 1999 S2 S8
2. National Osteoporosis Foundation: available at http://www.nof.org/ osteoporosis/diseasefacts.htm. Accessed: May 24, 2005.
3. L.J. Melton III, E.A. Chrischilles, C. Cooper, A.W. Lane, and B.L. Riggs Perspective: how many women have osteoporosis? J. Bone Miner. Res. 7 1992 1005 1010
4. NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and therapy. Osteoporosis, prevention, diagnosis, and therapy JAMA 285 2001 785 795
5. B.L. Riggs, and L.J. Melton III The worldwide problem of osteoporosis: insights afforded by epidemiology Bone 17 5 Suppl. 1995 505S 511S
6. J.A. Kanis, and O. Johnell Requirements for DXA for the management of osteoporosis in Europe Osteoporos. Int. 16 2004 229 238
7. B. Gullberg, O. Johnell, and J.A. Kanis World-wide projections for hip fracture Osteoporos. Int. 7 1997 407 413
8. S.R. Cummings, and J.R. Melton III Epidemiology and outcomes of osteoporotic fractures Lancet 359 2002 1761 1767
9. L.J. Melton III, O. Johnell, E. Lau, C.A. Mautelen, and E. Seeman Osteoporosis and the global competition for health care resources J. Bone Miner. Res. 19 2004 1055 1058
10. P.D. Delmas, and M. Fraser European Union challenges member states to fight the 'silent epidemic' of osteoporosis Eurohealth 4 4 1998 1 4
11. J.A. Kanis Diagnosis of osteoporosis and assessment of fracture risk Lancet 359 2002 1929 1936
12. WHO assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843, Geneva, Switzerland; 1994.
13. J.A. Kanis, O. Johnell, C. De Laet, H. Johansson, A. Oden, and P. Delmas A meta-analysis of previous fracture and subsequent fracture risk Bone 35 2004 375 382
14. J.A. Kanis, H. Johansson, A. Oden, O. Johnell, C. De Laet, and J.A. Eisman A family history of fracture and fracture risk: a meta-analysis Bone 35 2004 1029 1037
15. P. Garnero, and P.D. Delmas Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women J. Musculoskelet. Neuronal Interact. 4 2004 50 63
16. O. Johnell, A. Oden, C. De Laet, P. Garnero, P.D. Delmas, and J.A. Kanis Biochemical indices of bone turnover and the assessment of fracture probability Osteoporos. Int. 13 2002 523 526
17. P.J. Meunier, P.D. Delmas, R. Eastell, M.R. McClung, S. Papapoulos, and R. Rizzoli Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines Clin. Ther. 21 1999 1025 1044
18. S.C. Schuit, M. van der Klift, A.E. Weel, C.E. de Laet, H. Burger, and E. Seeman Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study Bone 34 2004 195 202
19. J. Kanis, F. Borgstrom, C. De Laet, H. Johansson, O. Johnell, and B. Jonsson Assessment of fracture risk Osteoporos. Int. 16 2005 581 589
20. J.A. Kanis, O. Johnell, A. Oden, A. Dawson, C. De Laet, and B. Johnsson Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds Osteoporos. Int. 12 2001 989 995
21. P.D. Delmas, H.K. Genant, C.G. Crans, J.L. Stock, M. Wong, and E. Siris Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial Bone 33 2003 522 532
22. R. Lindsay, S.L. Silverman, C. Cooper, D.A. Hanley, I. Barton, and S.B. Broy Risk of new vertebral fracture in the year following a fracture JAMA 285 2001 320 323
23. O. Johnell, J.A. Kanis, A. Odén, I. Sernbo, I. Redlund-Johnell, and C. Petterson Fracture risk following an osteoporotic fracture Osteoporos. Int. 15 2004 175 179
24. P.D. Delmas, and E. Seeman Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy Bone 34 2004 599 604
25. P.D. Delmas Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis Bone 30 2002 14 17
26. J.A. Kanis, D. Black, C. Cooper, P. Dargent, B. Dawson-Hughes, and C. De Laet International Osteoporosis Foundation; National Osteoporosis Foundation. A new approach to the development of assessment guidelines for osteoporosis Osteoporos. Int. 13 2002 527 536
27. T.W. O'Neill, D. Felsenberg, J. Varlow, C. Cooper, J.A. Kanis Silman A and the European Vertebral Osteoporosis Study Group The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study J. Bone Miner. Res. 11 1996 1010 1018
28. T.P. Van Staa, H.G. Leufkens, and C. Cooper Does a fracture at one site predict later fractures at other sites? A British cohort study Osteoporos. Int. 13 2002 624 629
29. J.A. Cauley, D.E. Thompson, K.C. Ensrud, J.C. Scott, and D. Black Risk of mortality following clinical fractures Osteoporos. Int. 11 2000 556 561
30. O. Johnell, J.A. Kanis, A. Oden, I. Sernbo, I. Redlund-Johnell, and C. Petterson Mortality after osteoporotic fractures Osteoporos. Int. 15 2004 38 42
31. A.G. Randell, T.V. Nguyen, N. Bhalerao, S.L. Silverman, P.N. Sambrook, and J.A. Eisman Deterioration in the quality of life following hip fracture: a prospective study Osteoporos. Int. 11 2000 460 466
32. I. Hallberg, A.M. Rosenqvist, L. Kartous, O. Löfman, O. Wahlström, and G. Toss Health-related quality of life after osteoporotic fractures Osteoporos. Int. 15 2004 834 841
33. P.D. Delmas Treatment of postmenopausal osteoporosis Lancet 359 2002 2018 2026
34. H.J. Häuselmann, and R. Rizzoli A comprehensive review of treatments for postmenopausal osteoporosis Osteoporos. Int. 14 2003 2 12
35. S.R. Cummings, D.M. Black, D.E. Thompson, W.B. Applegate, E. Barrett-Connor, and T.A. Musliner Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA 280 1998 2077 2082
36. H.A.P. Pols, D. Felsenberg, D.A. Hanley, J. Štepán, M. Muòoz-Torres, and T.J. Wilkin Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study Osteoporos. Int. 9 1999 461 468
37. Perrault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, et al. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiology and Drug Safety, John Wiley and Sons Ltd.; in press. www.interscience.wiley.com.
38. D. Briancon, J.B. de Gaudemar, and R. Forestier Management of osteoporosis in women with peripheral osteoporotic fractures after 50 years of age: a study of practices Jt. Bone Spine 71 2004 128 130
39. D.H. Solomon, C. Morris, H. Cheng, D. Cabral, J.N. Katz, and J.S. Finkelstein Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions Mayo Clin. Proc. 80 2005 194 202
40. S. Puffer, D.J. Torgerson, D. Sykes, P. Brown, and C. Cooper Health care costs of women with symptomatic vertebral fractures Bone 35 2004 383 386
41. H.K. Kamel, M.S. Hussain, S. Tariq, H.M. Perry III, and J.E. Morley Failure to diagnose and treat osteoporosis in elderly patients hospitalised with hip fracture Am. J. Med. 109 2000 326 328
42. E.S. Siris, P.D. Miller, E. Barrett-Connor, K.G. Faulkner, L.E. Wehren, and T.A. Abbott Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the national osteoporosis risk assessment JAMA 286 2001 2815 2822
43. International Osteoporosis Foundation Survey by Helmut Minne, November 1999.
44. D.H. Solomon, A. Brookhart, T.K. Ghandi, A. Karson, S. Gharib, and E.J. Oran Adherence with osteoporosis guidelines: a multilevel analysis of patient, physician, and practice setting characteristics Am. J. Med. 117 2004 919 924
45. L.M. Kern, N.R. Powe, M.A. Levine, A.L. Fitzpatrick, T.B. Harris, and J. Robbins Association between screening for osteoporosis and the incidence of hip fracture Ann. Intern. Med. 142 2005 173 181
46. J.G. Brecht, H.P. Kruse, W. Mohrke, A. Oestreich, and E. Huppertz Health-economic comparison of three recommended drugs for the treatment of osteoporosis Int. J. Clin. Pharmacol. Res. 24 2004 1 10